REG - CAP-XX Limited - Directors' Subscription

CAP-XXAnnouncement

29/11/2024 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241129:nRSc1987Oa&default-theme=true

RNS Number : 1987O  CAP-XX Limited  29 November 2024

29 November 2024

CAP-XX Limited

("CAP-XX" or "the Company")

Directors' Subscription

Total voting rights

CAP-XX Limited (AIM:CPX), a world leader in the design and manufacture of
thin, prismatic supercapacitors and energy management systems, announces an
update on the subscription for new ordinary shares in the Company by certain
directors of the Company (the "Directors' Subscription"), details of which
were set out in the announcement of the Company's recent fundraise on 31
October 2024 (the "Launch Announcement").

Following the publication of the annual report and accounts for the financial
year ended 30 June 2024, Dr Graham Cooley and Peter Fraser (the "Participating
Directors") have conditionally subscribed for a total of approximately £0.25m
(before expenses) of new Ordinary Shares pursuant to the Directors'
Subscription. The Directors' Subscription will result in the issue and
allotment of a total of 227,272,700 new Ordinary Shares (the "Subscription
Shares") and is being carried out at the same issue price of 0.11 pence and
substantially identical terms as those of the Placing. Details of the number
of Subscription Shares being subscribed for and the resultant holdings of the
Participating Directors are set out below.

 Director          Current holding of Ordinary Shares  Number of                                  Resultant holding of Ordinary Shares  Percentage of enlarged share capital* (%)

Subscription Shares being subscribed for
 Dr Graham Cooley  355,000,000                         218,181,800                                573,181,800                           9.98%
 Peter Fraser      -                                   9,090,900                                  9,090,900                             0.16%
 Total             355,000,000                         227,272,700                                582,272,700

 

* the current issued share capital of 3,357,210,402 Ordinary Shares as
enlarged by the 1,908,743,235 Second Placing Shares, the Subscription Shares
and the 250,000,000 Retail Offer Shares.

The FCA notification, made in accordance with the requirements of the UK
Market Abuse Regulation, is appended further below.

Related Party Transaction

Dr Graham Cooley is a substantial shareholder and director of the Company and
Peter Fraser is a director of the Company. Therefore the Participating
Directors are deemed to be related parties pursuant to the AIM Rules for
Companies (the "AIM Rules").

The Directors' Subscription constitutes a related party transaction in
accordance with Rule 13 of the AIM Rules. Accordingly, the independent
Directors (being Patrick Elliot, Steen Feldskov, Dr Anthony Sive and Lars
Stegmann) consider, having consulted with the Company's Nominated Adviser,
Allenby Capital Limited, that the terms of the Directors' Subscription are
fair and reasonable insofar as the Company's shareholders are concerned.

Application for admission to trading on AIM and total voting rights

Application has been made for the Subscription Shares to be admitted to
trading on AIM and it is anticipated that this will take place at 8.00 a.m. on
or around 9 December 2024, at the same time as the admission of the Second
Placing Shares and the Retail Offer Shares ("Second Admission").

Following admission of the Subscription Shares and Second Admission, the
Company's issued ordinary share capital will comprise 5,743,226,337 Ordinary
Shares with one voting right each. The Company does not hold any Ordinary
Shares in treasury. Accordingly, the above figure may be used by Shareholders
as the denominator for the calculations by which they will determine if they
are required to notify their interest in, or a change to their interest in,
the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined, definitions contained in this announcement have the
same meaning as set out in the Launch Announcement.

For further information contact:

CAP-XX Limited

Pat Elliott
(Chairman)
+61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Piers Shimwell (Corporate Finance)
                                    +44 (0)
20 3328 5656

Jos Pinnington/Tony Quirke (Sales and Corporate Broking)

 

Notes to Editors:

About CAP-XX

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat
supercapacitors and energy management systems used in portable and small-scale
electronic devices, and to an increasing extent, in larger applications such
as automotive and renewable energy. The unique feature of CAP-XX
supercapacitors is their very high-power density and high energy storage
capacity in a space-efficient prismatic package. These attributes are
essential in power-hungry consumer and industrial electronics and deliver
similar benefits in automotive and other transportation applications. For more
information about CAP-XX, visit www.cap-xx.com (http://www.cap-xx.com)

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 1.  Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         1) Dr Graham Cooley

                                                                  2) Peter Fraser
 2.  Reason for the Notification
 a)  Position/status                                              1) Non-Executive Director

                                                                  2) Non-Executive Director
 b)  Initial notification/Amendment                               Initial Notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CAP-XX Limited
 b)  LEI                                                          213800HECUSIYXH3WN26
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the Financial instrument, type of instrument  Ordinary shares of no par value each
     Identification code                                          ISIN: AU0000XINAS1
 b)  Nature of the transaction                                    Subscription for Ordinary Shares
 c)  Price(s) and volume(s)                                       Price(s)                 Volume(s)
                                                                  1) 0.11 pence per share  218,181,800
                                                                  2) 0.11 pence per share  9,090,900
 d)  Aggregated information:                                      n/a

     -Aggregated volume

     -Price
 e)  Date of the transaction                                      29 November 2024 to be completed on 9 December 2024
 f)  Place of the transaction                                     Outside of a trading venue

d)

Aggregated information:

-Aggregated volume

-Price

n/a

e)

Date of the transaction

29 November 2024 to be completed on 9 December 2024

f)

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEKZMZMLLVGDZG